Market revenue in 2022 | USD 1,375.2 million |
Market revenue in 2030 | USD 2,012.2 million |
Growth rate | 4.9% (CAGR from 2022 to 2030) |
Largest segment | Polypropylene (pp) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene (PE), Polystyrene (PS), Polycarbonate (PC) |
Key market players worldwide | Dow Inc, SABIC, Eastman Chemical Co, Covestro AG, Evonik Industries AG, Sumitomo Chemical Co Ltd, Arkema SA, INEOS, Rutland Plastic Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical injection molded plastic market will help companies and investors design strategic landscapes.
Polypropylene (pp) was the largest segment with a revenue share of 34.39% in 2022. Horizon Databook has segmented the France medical injection molded plastic market based on polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene (pe), polystyrene (ps), polycarbonate (pc) covering the revenue growth of each sub-segment from 2019 to 2030.
France medical injection molded plastics market is expected to witness increased adoption of polypropylene-based internal and external use products, such as mesh implants, containers, and catheters, as a substitute for PVC-based products. In addition, the market is anticipated to witness increased adoption of polyethylene-based medica
bags, trays, and connecting components such as valves as these products can be easily sterilized. The COVID-19 pandemic has put immense pressure on the French medical system, which struggled heavily during the first and second waves.
To tackle the ongoing Omicron variant, the government of France announced a USD 8.33 billion (EUR 7 billion) public funding plan in June 2021, to improve the country’s medical system. This is expected to propel the demand for injection molded plastics in medical applications across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the France medical injection molded plastic market , including forecasts for subscribers. This country databook contains high-level insights into France medical injection molded plastic market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account